MedTrace Logo

Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients

NCT01334450 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-03-02

No results posted yet for this study

Summary

Transcranial Magnetic Stimulation (TMS) for treatment of Alzheimer disease.

Conditions

  • Alzheimer Disease

Interventions

DEVICE

TMS , H2-coil

Trans cranial magnetic stimulation with H2-coil

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Zeev Meiner, Dr. · Hadassah Medical Organization

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01334450 on ClinicalTrials.gov